The Dark Side of the Moon – the Side Effects of Therapy in a Dynamic Era of Breast Cancer Management

по Greil, Richard
Опубликовано 2009

Is Chemoendocrine Treatment without Alternative?

по Greil, Richard
Опубликовано 2008

Digging deep into “dirty” drugs – modulation of the methylation machinery

по Pleyer, Lisa, Greil, Richard
Опубликовано в: Drug Metab Rev (2015)

Response to comment by P. Vassilakopoulos and colleagues

по Jaeger, Ulrich, Praxmarer, Michael, Greil, Richard
Опубликовано в: Haematologica (2015)

Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis—Masters of Survival and Clonality?

по Pleyer, Lisa, Valent, Peter, Greil, Richard
Опубликовано в: Int J Mol Sci (2016)

ASCO-update: gastrointestinal tumors

по Weiss, Lukas, Huemer, Florian, Greil, Richard
Опубликовано в: Memo (2017)

Risks and chances of aberrant DNA repair in cancer

по Schubert, Maria, Greil, Richard, Geisberger, Roland
Опубликовано в: Oncoscience (2018)

Mouse models to decipher anti-tumor immunity

по Parigger, Thomas, Greil, Richard, Zaborsky, Nadja
Опубликовано в: Oncotarget (2019)

IDO in MDS/AML disease progression and its role in resistance to azacitidine: a potential new drug target?

по Leisch, Michael, Greil, Richard, Pleyer, Lisa
Опубликовано в: Br J Haematol (2020)

Neoadjuvant Chemotherapy and Targeted Therapy in Breast Cancer: Past, Present, and Future

по Gampenrieder, Simon P., Rinnerthaler, Gabriel, Greil, Richard
Опубликовано 2013

Bone-Targeted Therapy in Metastatic Breast Cancer – All Well-Established Knowledge?

по Gampenrieder, Simon P., Rinnerthaler, Gabriel, Greil, Richard
Опубликовано в: Breast Care (Basel) (2014)

CDK4/6 inhibition in luminal breast cancer

по Gampenrieder, Simon Peter, Rinnerthaler, Gabriel, Greil, Richard
Опубликовано в: Memo (2016)

SABCS 2016: systemic therapy for metastatic breast cancer

по Gampenrieder, Simon Peter, Rinnerthaler, Gabriel, Greil, Richard
Опубликовано в: Memo (2017)

Antiangiogenic therapy in breast cancer

по Gampenrieder, Simon Peter, Westphal, Theresa, Greil, Richard
Опубликовано в: Memo (2017)

SABCS 2017: lifestyle factors, hormone receptor-positive advanced disease, liquid biopsies, and prognosis

по Rinnerthaler, Gabriel, Gampenrieder, Simon Peter, Greil, Richard
Опубликовано в: Memo (2018)

ASCO 2018 highlights: metastatic breast cancer

по Rinnerthaler, Gabriel, Gampenrieder, Simon Peter, Greil, Richard
Опубликовано в: Memo (2018)

HER2 Directed Antibody-Drug-Conjugates beyond T-DM1 in Breast Cancer

по Rinnerthaler, Gabriel, Gampenrieder, Simon Peter, Greil, Richard
Опубликовано в: Int J Mol Sci (2019)

Everolimus in Postmenopausal, Hormone Receptor-Positive Advanced Breast Cancer: Summary and Results of an Austrian Expert Panel Discussion

по Gnant, Michael, Greil, Richard, Hubalek, Michael, Steger, Günther
Опубликовано 2013

Systemic effect of catumaxomab in a patient with metastasized colorectal cancer: a case report

по Bezan, Angelika, Hohla, Florian, Meissnitzer, Thomas, Greil, Richard
Опубликовано 2013

The Role of CD44 in the Pathophysiology of Chronic Lymphocytic Leukemia

по Gutjahr, Julia Christine, Greil, Richard, Hartmann, Tanja Nicole
Опубликовано в: Front Immunol (2015)